Cancer has quietly become the pharmaceutical industry’s most lucrative disease area. In 2024 alone, global cancer drug sales exceeded $200 billion, making oncology the single largest revenue category ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results